Recombinant Human Interleukin-11

What Recombinant Human Interleukin-11 Means in Everyday Medical Language

Recombinant Human Interleukin-11 is a medicine made in the laboratory that copies a natural protein called interleukin-11 (IL-11). IL-11 is produced by support cells in the bone marrow and helps the body grow blood cells, especially platelets. Platelets are small blood cells that help stop bleeding by forming clots. The lab-made medicine is also known by other names such as Neumega, oprelvekin, or rhIL-11. These names all refer to the same medicine or closely related forms.

Why Recombinant Human Interleukin-11 Can Matter in Cancer Care

Chemotherapy, a common treatment for cancer, can lower the number of platelets in the blood. This condition, called thrombocytopenia, increases the risk of bleeding and bruising. To help reduce this risk, doctors may use recombinant human interleukin-11 to encourage the bone marrow to produce more platelets. By raising platelet counts, this medicine can help patients avoid serious bleeding problems and reduce the need for platelet transfusions during chemotherapy.

What Patients Might See or Hear About Recombinant Human Interleukin-11

You might see this medicine mentioned in your medical records, treatment plans, or drug information under different names like Neumega, oprelvekin, recombinant human interleukin-11, or rhIL-11. Because these terms can look confusing or appear in different ways, it’s important to ask your healthcare team what they mean in your specific situation. They can explain whether the term refers to the medicine, the natural protein, or something else. Understanding this helps you stay informed about your care.

Common Sources of Confusion and Related Terms

The terms recombinant human interleukin-11, Neumega, oprelvekin, and rhIL-11 all refer to the same lab-made protein used to increase platelet counts. However, the term interleukin-11 (IL-11) can also refer to the natural protein in the body or sometimes unrelated things like place names or roads. This can cause confusion if the term appears without explanation. Always check with your healthcare provider to understand how these terms relate to your care.

How to Read Recombinant Human Interleukin-11 in Context and What It Does Not Mean

Seeing the term recombinant human interleukin-11 or related names alone does not mean a diagnosis or a treatment decision. These terms need context to understand their meaning. For example, they might appear as part of a lab test, a drug name, or research information. They do not by themselves indicate a problem or a specific treatment plan. Always ask your care team what these terms mean in your medical records or discussions to avoid misunderstanding.

Safety and Next Steps

This information is meant to educate and does not replace medical advice. If you see recombinant human interleukin-11 or related terms in your care, the best next step is to ask your healthcare team to explain what it means for you personally. They can clarify how it fits into your diagnosis, treatment, or monitoring. Understanding this helps you be informed and involved in your care decisions.